Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: Essential need to use orthogonal methods to assure the quality of therapeutic protein products
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 99 (5) , 2200-2208
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Evaluation of a Dual-Wavelength Size Exclusion HPLC Method With Improved Sensitivity to Detect Protein Aggregates and Its Use to Better Characterize Degradation Pathways of an IgG1 Monoclonal AntibodyJournal of Pharmaceutical Sciences, 2010
- A Multi-Tiered Analytical Approach For the Analysis and Quantitation of High-Molecular-Weight Aggregates in a Recombinant Therapeutic GlycoproteinThe AAPS Journal, 2009
- A Bayesian Approach for Quantifying Trace Amounts of Antibody Aggregates by Sedimentation Velocity Analytical UltracentrifugationThe AAPS Journal, 2008
- Quantitation of Aggregate Levels in a Recombinant Humanized Monoclonal Antibody Formulation by Size-Exclusion Chromatography, Asymmetrical Flow Field Flow Fractionation, and Sedimentation VelocityJournal of Pharmaceutical Sciences, 2007
- Urgent inhibitor issues: targets for expanded researchHaemophilia, 2006
- Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticalsThe AAPS Journal, 2006
- A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregationThe AAPS Journal, 2006
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Is any measurement method optimal for all aggregate sizes and types?The AAPS Journal, 2006
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006